ARCHIVES

Bristol Stock Drops Amid New Setbacks, Deepening Firm’s Decline In Oncology

This article is from The Cancer Letter archive.

Vol. 28 No. 14 | April 5, 2002

Download PDF Visit The Full Archive

Related Articles

Letrozole cuts risk of recurrent breast cancer in post-menopausal women.

October 17, 2003

Michigan’s Zhang Wins “Protein Science Olympics”

January 14, 2011

In Brief: Parkinson To Leave CTEP For Novartis; FTC To Permit Sandoz, Ciba-Geigy Merger

January 10, 1997

Mack, Specter Hit White House Budget Proposal For NIH.

February 18, 2000

Survey Shows That One-Third Of Patients Are Undertreated

April 27, 2012

ACS To Accept Database On Method Of Unconventional Rx

November 26, 1993